How many patents does
Targacept have?
patents
909
families
77
granted
175
applications
734
US
146
EP
79
WO
55
CN
52
KR
32
JP
28
RoW
517
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Targacept
Top ten assignees appearing on patents
2009 - 2018
| targacept | 774 |
| astrazeneca | 37 |
| catalyst biosciences | 8 |
| attenua | 8 |
| atacama therapeutics | 6 |
| targasept | 6 |
| oyster point pharma | 6 |
| r.j. reynolds tobacco company | 2 |
| atcama therapeutics | 1 |
| ericsson, caroline | 1 |
2009
| targacept | 103 |
| astrazeneca | 10 |
| r.j. reynolds tobacco company | 2 |
| aventis pharma | 1 |
Targacept
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide,… 🛈 | 86 | 2007 |
| nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes | 70 | 2006 |
| arylvinylazacycloalkane compounds and methods of preparation and use thereof | 57 | 2003 |
| a process for the preparation of tert-butyl (r) - 3 -vinylpyrrolidine- i - carboxylate a… 🛈 | 50 | 2008 |
| nicotinic receptor non-competitive antagonists | 43 | 2010 |
| preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyc… 🛈 | 39 | 2009 |
| hydroxybenzoate salts of metanicotine compounds | 34 | 2004 |
| synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine | 33 | 2008 |
| combination of alpha 7 nicotinic agonists and antipsychotics | 28 | 2008 |
| 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof | 27 | 1998 |